Aktsiaselts Infortar Unaudited Consolidated Interim Report For Third Quarter Of 2025
|   KEY FIGURES  |  Q3 2025 | Q3 2024 | 9 months 2025 | 9 months 2024 | 
| Sales revenue. m€ | 467.693 | 349.468 | 1 419.562 | 925.607 | 
| Gross profit. m€ | 95.829 | 40.669 | 177.565 | 93.758 | 
| EBITDA. m€ | 104.926 | 41.874 | 189.977 | 117.384 | 
| EBITDA margin (%) | 22.4% | 12.0% | 13.4% | 12.7% | 
| Net profit. EBIT. m€ | 64.836 | 20.422 | 91.220 | 83.817 | 
| Total profit(-loss). m€ | 72.239 | 114.322 | 57.828 | 187.339 | 
| Net profit (-loss) holders of the Parent m€ | 59.068 | 111.105 | 56.519 | 184.122 | 
| 30.09.2025 | 31.12.2024 | |||
| EPS (euros)* | 2.8 | 9.1 | ||
| Total equity m€ | 1 203.956 | 1 166.221 | ||
| Total liabilities m€ | 1 035.423 | 1 223.287 | ||
| Net debt m€ | 899.281 | 1 055.708 | ||
| Investment loans to EBITDA (ratio)** | 4.2 | 4 | 
Notes: *EPS (in euros) is calculated as: profit/loss attributable to the owners of the parent * 1000 / number of shares of which own shares are excluded. ** Investment loans / EBITDA. annualized. For comparability actual EBITDA of Tallink Grupp for the relevant period has been used.
Revenue
During the first nine months of 2025. Infortar's consolidated revenue increased by €493. 955 million reaching €1 419.6 million compared to €925.607 million in the same period in 2024. A positive impact came from the addition of new companies to the consolidation group compared to the previous year.
EBITDA and Segment Reporting
In the nine months of the 2025 financial year the EBITDA of the maritime transport segment amounted to EUR 102.5 million (9 months 2024: EUR 149.5 million).
Energy Segment: Nine-month EBITDA for 2025 was €76.5 million down from €79.5 million in 2024.
Real Estate Segment: EBITDA for real estate in the first nine months of 2025 reached €11 million. up from €11 million in the same period of 2024. In the real estate segment. the assessment of profitability takes into account the EBITDA of separate real estate companies.
Net Profit
Consolidated net profit for the first nine months of 2025 was €57.828 million compared to €187.339 million for the same period in 2024. The previous year results included a one-time profit from the Tallink acquisition.
Financing
Loan and lease obligations totalled €1 035.4 million for the first nine months of 2025 down from €1 166.2 million in 2024 mainly due to the consolidation of Tallink liabilities. The net debt EBITDA is 4.2.
STATEMENT OF FINANCIAL POSITION
| (in thousands of EUR) | 30.09.25 | 31.12.24 | 
| Current assets | ||
| Cash and cash equivalents | 136 142 | 167 579 | 
| Derivative financial assets | 8 675 | 8 333 | 
| Settled derivative receivables | 11 203 | 676 | 
| Other prepayments and receivables | 108 491 | 155 351 | 
| Prepayments for taxes | 4 005 | 3 831 | 
| Trade and other receivables | 40 764 | 38 517 | 
| Prepayments for inventories | 565 | 2 498 | 
| Inventories | 164 238 | 215 914 | 
| Biological assets | 499 | 941 | 
| Total current assets | 474 582 | 593 640 | 
| Non-current assets | 30.09.25 | 31.12.24 | 
| Investments to associates | 20 449 | 16 603 | 
| Long-term derivative instruments | 579 | 3 214 | 
| Other long term obligations | 32 642 | 35 163 | 
| Property, plant and equipment at fair value | 1 211 907 | 1 315 167 | 
| Investment property | 68 510 | 67 931 | 
| Property, plant and equipment | 653 410 | 594 291 | 
| Intangible assets | 37 748 | 38 874 | 
| Right-of-use assets | 34 833 | 47 598 | 
| Biological assets | 7 891 | 2 753 | 
| Total non-current assets | 2 067 969 | 2 121 594 | 
| TOTAL ASSETS | 2 542 551 | 2 715 234 | 
| (in thousands of EUR) | 30.09.25 | 31.12.24 | 
| Current liabilities | ||
| Loan liabilities | 284 430 | 497 162 | 
| Rental liabilities | 8 839 | 9 020 | 
| Payables to suppliers | 97 393 | 87 941 | 
| Tax obligations | 42 583 | 49 354 | 
| Buyers' advances | 40 516 | 31 126 | 
| Settled derivatives | 212 | 8 728 | 
| Other current liabilities | 58 556 | 63 431 | 
| Short term derivatives | 7 672 | 27 704 | 
| Total current liabilities | 540 201 | 774 466 | 
| Non-current liabilities | 30.09.25 | 31.12.24 | 
| Long-term provisions | 6 270 | 9 946 | 
| Deferred taxes | 3 227 | 2 816 | 
| Other long-term liabilities | 44 946 | 43 209 | 
| Long-term derivatives | 1 797 | 1 471 | 
| Loan-liabilities | 709 824 | 676 670 | 
| Rental liabilities | 32 330 | 40 435 | 
| Total non-current liabilities | 798 394 | 774 547 | 
| TOTAL LIABILITIES | 1 338 595 | 1 549 013 | 
| (in thousands of EUR) | 30.09.25 | 31.12.24 | 
| Equity | ||
| Share capital | 2 117 | 2 117 | 
| Own shares | -51 | -72 | 
| Share premium | 32 484 | 32 484 | 
| Reserve capital | 212 | 212 | 
| Option reserve | 7 422 | 6 223 | 
| Hedging reserve | -578 | -21 674 | 
| Unrealised currency translation differences | -3 | 45 | 
| Employment benefit reserve | -44 | -185 | 
| Retained earnings | 908 175 | 890 167 | 
| Total equity attributable to equity holders of the Parent | 949 734 | 909 317 | 
| Minority interests | 254 222 | 256 904 | 
| Total equity | 1 203 956 | 1 166 221 | 
| TOTAL LIABILITIES AND EQUITY | 2 542 551 | 2 715 234 | 
INCOME STATEMENT
| (in thousands of EUR) |  Q3  2025  |   Q3  2024  |   9 M 2025  |   9 M  2024  | 
| Revenue | 467 693 | 349 468 | 1 419 562 | 925 607 | 
| Cost of goods (goods and services) sold | -371 837 | -308 803 | -1 241 781 | -831 796 | 
| Write-down of receivables | -28 | 4 | -217 | -53 | 
| Gross profit | 95 828 | 40 669 | 177 564 | 93 758 | 
| Marketing expenses | -11 123 | -7 789 | -34 218 | -8 627 | 
| General administrative expenses | -18 804 | -13 423 | -62 325 | -27 679 | 
| Profit (loss) from derivatives | -1 145 | 52 | 8 037 | 24 574 | 
| Profit (loss) from biological assets | 4 511 | 44 | 4 615 | 17 | 
| Profit (loss) from the change in the fair value of the investment property | 0 | -3 047 | 0 | -2 891 | 
| Profit (loss) from the change in the fair value of the investment property | -5 607 | 0 | -5 607 | 0 | 
| Other operating revenue | 2 237 | 4 368 | 6 473 | 5 449 | 
| Other operating expenses | -1 061 | -452 | -3 320 | -784 | 
| Operating profit | 64 836 | 20 422 | 91 219 | 83 817 | 
| (in thousands of EUR) |  Q3  2025  |   Q3  2024  |   9 M 2025  |   9 M  2024  | 
| Profit (loss) from investments accounted for by equity method | 619 | 3 243 | 1 940 | 22 128 | 
| Financial income and expenses: | ||||
| Other financial investments | 17 595 | 69 782 | 16 984 | 72 520 | 
| Interest expense | -10 323 | -11 340 | -34 800 | -24 466 | 
| Interest income | 609 | 1 215 | 2 346 | 4 219 | 
| Profit (loss) from changes in exchange rates | 388 | 160 | 2 | 156 | 
| Other financial income and expenses | -705 | -393 | -1 977 | -395 | 
| Total financial income and expenses | 7 564 | 59 424 | -17 445 | 52 034 | 
| Profit before tax | 73 019 | 83 089 | 75 714 | 157 979 | 
| Corporate income tax | -780 | 31 233 | -17 886 | 29 360 | 
| Profit for the financial year | 72 239 | 114 322 | 57 828 | 187 339 | 
| including: | ||||
| Profit attributable to the owners of the parent company | 59 068 | 111 105 | 56 519 | 184 122 | 
| Profit attributable to non-controlling interest | 13 171 | 3 217 | 1 309 | 3 217 | 
| Other comprehensive income |  9 months 2025  |   9 months  2024  | ||
| Items that may be subsequently reclassified to the income statement: | ||||
| Revaluation of risk hedging instruments | 21 237 | 0 | ||
| Exchange rate differences attributable to foreign subsidiaries | -48 | -33 516 | ||
| Total of other comprehensive income | 21 189 | -33 516 | ||
| Total income | 79 017 | 153 823 | ||
| including: | ||||
| Comprehensive profit attributable to the owners of the parent company | 77 708 | 0 | ||
| Comprehensive profit attributable to non-controlling interest | 1 309 | 150 659 | ||
| Ordinary earnings per share (in euros per share) | 2,75 | 9,11 | ||
| Diluted earnings per share (in euros per share) | 2,68 | 8,78 | 
CASH FLOW STATEMENT
| Cash flows from operating activities | ||
| (in thousands of EUR) |  9 months  2024  |   9 months  2024  | 
| Profit for the financial year | 57 828 | 187 339 | 
| Adjustments: | ||
| Depreciation, amortisation, and impairment of non-current assets | 98 758 | 33 567 | 
| Equity profits/losses | -1 940 | -156 017 | 
| Change in the value of derivatives | -17 413 | 26 156 | 
| Other financial income/expenses | -21 797 | -66 | 
| Calculated interest expenses | 34 800 | 24 466 | 
| Profit/loss from non-current assets sold | -706 | -301 | 
| Income from grants recognised as revenue | -1 079 | -319 | 
| Corporate income tax expense | 17 886 | -29 360 | 
| Income tax paid | -17 475 | -1 482 | 
| Change in receivables and prepayments related to operating activities | 35 661 | 79 126 | 
| Change in inventories | 57 722 | -22 986 | 
| Change in payables and prepayments relating to operating activities | -7 995 | 35 968 | 
| Change in biological assets | 232 | 112 | 
| Total cash flows from operating activities | 255 719 | 176 203 | 
| Cash flows from investing activities |  9 months  2024  |   9 months  2024  | 
| Purchase of investments in associates | -1 332 | 0 | 
| Proceeds from disposal of investments in associates | ||
| Purchases of subsidiaries | -39 927 | -67 810 | 
| Given loans | 2 708 | 2 057 | 
| Interest gain | 2 134 | 4 019 | 
| Purchases Investment property | -2 116 | -10 566 | 
| Purchases of property, plant and equipment | -52 605 | -17 042 | 
| Proceeds from sale of property | 78 110 | 707 | 
| Total cash flows used in investing activities | -13 028 | -67 773 | 
| Cash flows used in financing activities |  9 months  2024  |   9 months  2024  | 
| Gain from goverment grants | 2 638 | 0 | 
| Changes in overdraft | -43 513 | -30 457 | 
| Proceeds from borrowings | 99 173 | 106 303 | 
| Repayments of borrowings | -245 306 | -114 706 | 
| Repayment of finance lease liabilities | -11 703 | -8 674 | 
| Interest paid | -34 088 | -24 968 | 
| Dividends paid | -38 511 | -30 332 | 
| Gain from share emission | 22 | 3 152 | 
| Total cash flows used in financing activities | -274 128 | -99 682 | 
| 0 | 0 | |
| TOTAL NET CASH FLOW | -31 437 | 8 748 | 
| Cash at the beginning of the year | 167 579 | 87 115 | 
| Cash at the end of the period | 136 142 | 95 863 | 
| Net (decrease)/increase in cash | -31 437 | 8 748 | 
Infortar operates in seven countries. the company's main fields of activity are maritime transport. energy and real estate. Infortar owns a 68.47% share in Tallink Grupp. a 100% share in Elenger Grupp and a versatile and modern real estate portfolio of approx. 141.000 m2. In addition to the three main areas of activity. Infortar also operates in agriculture, engineering, construction minerals, printing sector, services and other areas. A total of 110 companies belong to the Infortar group: 101 subsidiaries 4 affiliated companies and 5 subsidiaries of affiliated companies. Excluding affiliates Infortar employs 6558 people.
Additional information:
Kadri Laanvee
Investor Relations Manager
Phone: +372 5156662
e-mail: ... 
Attachments
-  
   
  Q3_2025 report ENG 
   
  Q3_2025 presentation ENG
 

   Legal Disclaimer:
 MENAFN provides the
              information “as is” without warranty of any kind. We do not accept
              any responsibility or liability for the accuracy, content, images,
              videos, licenses, completeness, legality, or reliability of the information
              contained in this article. If you have any complaints or copyright
              issues related to this article, kindly contact the provider above.

                
                
                
                
                
                
    
                       
                       
                       
                       
                       
                       
                       
                       
                       
Comments
No comment